GetTopicDetailResponse(id=bb7332335bd, topicName=利魯唑, introduction=利魯唑, content=null, image=null, comments=2, allHits=1570, url=https://h5.medsci.cn/topic?id=32335, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=71291, tagList=[TagDto(tagId=71291, tagName=利魯唑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2257281, encodeId=b781225e28114, content=<a href='/topic/show?id=0a9e922085f' target=_blank style='color:#2F92EE;'>#貝伐珠單抗#</a> <a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a> <a href='/topic/show?id=ae4d11646ed' target=_blank style='color:#2F92EE;'>#mFOLFOX6#</a> <a href='/topic/show?id=bb7332335bd' target=_blank style='color:#2F92EE;'>#利魯唑#</a>, objectTitle=Clin Cancer Res：利魯唑聯(lián)合mFOLFOX6和貝伐珠單抗治療轉(zhuǎn)移性結(jié)直腸癌：一項(xiàng)I期臨床試驗(yàn), objectType=article, longId=868341, objectId=9d8c86834161, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240806/1722908667203_8538692.png, objectUrl=/article/show_article.do?id=9d8c86834161, replyNumber=0, likeNumber=29, createdTime=2025-03-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=9d8c86834161, moduleTitle=Clin Cancer Res：利魯唑聯(lián)合mFOLFOX6和貝伐珠單抗治療轉(zhuǎn)移性結(jié)直腸癌：一項(xiàng)I期臨床試驗(yàn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9d8c86834161)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2183816, encodeId=9ff9218381688, content=<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲雙胍#</a> <a href='/topic/show?id=f669432334f' target=_blank style='color:#2F92EE;'>#多巴胺能神經(jīng)元#</a> <a href='/topic/show?id=bb7332335bd' target=_blank style='color:#2F92EE;'>#利魯唑#</a> <a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>, objectTitle=新冠傷腦？Cell子刊最新：新冠病毒損傷神經(jīng)系統(tǒng)的新原因找到了！但二甲雙胍等藥物能阻斷病毒, objectType=article, longId=810821, objectId=a53a8108210e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240125/1706145475513_5651580.png, objectUrl=/article/show_article.do?id=a53a8108210e, replyNumber=0, likeNumber=146, createdTime=2024-01-25, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a53a8108210e, moduleTitle=新冠傷腦？Cell子刊最新：新冠病毒損傷神經(jīng)系統(tǒng)的新原因找到了！但二甲雙胍等藥物能阻斷病毒, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a53a8108210e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2018351, encodeId=4214201835181, content=<a href='/topic/show?id=bb7332335bd' target=_blank style='color:#2F92EE;'>#利魯唑#</a>, objectTitle=Lancet Neurology：利魯唑治療退行性頸椎病減壓手術(shù)患者的安全性和有效性：一項(xiàng)多中心、雙盲、安慰劑對(duì)照、隨機(jī)、3期試驗(yàn) , objectType=article, longId=207349, objectId=a3c320e349ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3c320e349ac, replyNumber=0, likeNumber=0, createdTime=2021-10-14, rootId=0, userName=venlin, userId=aae2431, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3c320e349ac, moduleTitle=Lancet Neurology：利魯唑治療退行性頸椎病減壓手術(shù)患者的安全性和有效性：一項(xiàng)多中心、雙盲、安慰劑對(duì)照、隨機(jī)、3期試驗(yàn) , moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a3c320e349ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2018350, encodeId=e5222018350ea, content=<a href='/topic/show?id=bb7332335bd' target=_blank style='color:#2F92EE;'>#利魯唑#</a>, objectTitle=Lancet neurol：Riluzole（利魯唑）可延長(zhǎng)4期肌萎縮側(cè)索硬化癥患者存活期，但對(duì)早期患者無(wú)明顯影響, objectType=article, longId=131823, objectId=327c13182330, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=327c13182330, replyNumber=0, likeNumber=86, createdTime=2018-05-17, rootId=0, userName=venlin, userId=aae2431, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=327c13182330, moduleTitle=Lancet neurol：Riluzole（利魯唑）可延長(zhǎng)4期肌萎縮側(cè)索硬化癥患者存活期，但對(duì)早期患者無(wú)明顯影響, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=327c13182330)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
